Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
112M
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
74.2M
-
Shares change
-
+7.55M
-
Total reported value, excl. options
-
$1.2B
-
Value change
-
+$120M
-
Put/Call ratio
-
0.52
-
Number of buys
-
111
-
Number of sells
-
-90
-
Price
-
$16.21
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q2 2023
265 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q2 2023.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74.2M shares
of 112M outstanding shares and own 66.07% of the company stock.
Largest 10 shareholders include FMR LLC (15M shares), BlackRock Inc. (6.89M shares), VANGUARD GROUP INC (5.11M shares), STATE STREET CORP (4.82M shares), VIKING GLOBAL INVESTORS LP (3.54M shares), ALLIANCEBERNSTEIN L.P. (2.96M shares), Boxer Capital, LLC (2M shares), GEODE CAPITAL MANAGEMENT, LLC (1.85M shares), MILLENNIUM MANAGEMENT LLC (1.82M shares), and WASATCH ADVISORS LP (1.71M shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.